Sensei Biotherapeutics Statistics
Total Valuation
SNSE has a market cap or net worth of $13.19 million. The enterprise value is -$12.88 million.
Important Dates
The next estimated earnings date is Thursday, November 13, 2025, before market open.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SNSE has 1.26 million shares outstanding. The number of shares has increased by 0.14% in one year.
| Current Share Class | 1.26M |
| Shares Outstanding | 1.26M |
| Shares Change (YoY) | +0.14% |
| Shares Change (QoQ) | +0.10% |
| Owned by Insiders (%) | 2.30% |
| Owned by Institutions (%) | 6.18% |
| Float | 828,299 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.48 |
| P/TBV Ratio | 0.48 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.64, with a Debt / Equity ratio of 0.09.
| Current Ratio | 7.64 |
| Quick Ratio | 7.39 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -441.41 |
Financial Efficiency
Return on equity (ROE) is -67.47% and return on invested capital (ROIC) is -38.64%.
| Return on Equity (ROE) | -67.47% |
| Return on Assets (ROA) | -36.75% |
| Return on Invested Capital (ROIC) | -38.64% |
| Return on Capital Employed (ROCE) | -96.47% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.79M |
| Employee Count | 15 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.89% in the last 52 weeks. The beta is 0.31, so SNSE's price volatility has been lower than the market average.
| Beta (5Y) | 0.31 |
| 52-Week Price Change | -15.89% |
| 50-Day Moving Average | 9.54 |
| 200-Day Moving Average | 8.55 |
| Relative Strength Index (RSI) | 48.42 |
| Average Volume (20 Days) | 62,781 |
Short Selling Information
The latest short interest is 9,467, so 0.75% of the outstanding shares have been sold short.
| Short Interest | 9,467 |
| Short Previous Month | 10,390 |
| Short % of Shares Out | 0.75% |
| Short % of Float | 1.14% |
| Short Ratio (days to cover) | 2.42 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -26.93M |
| Pretax Income | -26.82M |
| Net Income | -26.82M |
| EBITDA | -26.19M |
| EBIT | -26.93M |
| Earnings Per Share (EPS) | -$21.30 |
Full Income Statement Balance Sheet
The company has $28.63 million in cash and $2.56 million in debt, giving a net cash position of $26.07 million or $20.67 per share.
| Cash & Cash Equivalents | 28.63M |
| Total Debt | 2.56M |
| Net Cash | 26.07M |
| Net Cash Per Share | $20.67 |
| Equity (Book Value) | 27.31M |
| Book Value Per Share | 21.66 |
| Working Capital | 25.70M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$24.27 million and capital expenditures -$16,000, giving a free cash flow of -$24.28 million.
| Operating Cash Flow | -24.27M |
| Capital Expenditures | -16,000 |
| Free Cash Flow | -24.28M |
| FCF Per Share | -$19.25 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SNSE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.14% |
| Shareholder Yield | -0.14% |
| Earnings Yield | -203.31% |
| FCF Yield | -184.04% |
Analyst Forecast
The average price target for SNSE is $72.50, which is 593.12% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $72.50 |
| Price Target Difference | 593.12% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -12.76% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 17, 2025. It was a reverse split with a ratio of 1:20.
| Last Split Date | Jun 17, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |